Company Will Have Over $500M CashBy the end of today and unfettered access to another $60M under its revolver. Wow scripts data over the last couple of weeks in North America indicates that the company's market share in its major drugs is either stabilizing or improving. High single digit growth is expected out of the UK from dozens of product launches over the next couple of years. Those launches will be accelerated with the new cash on hand. Company will also execute on product acquisitions to grow EBITDA. The short thesis has run its course. Smart money is going long. Short posters on this board work for hedge funds who still have significant short positions that they need to unwind. They can't do that in one day or even one week otherwise they will drive the share price higher. If you hold shares and are truly long this company, place a very high ask price for your shares and do not use stop losses. The long pain is almost over.